MANIPULATION OF CELL-CYCLE KINETICS - INFLUENCE ON THE CYTOTOXICITY OF DOXORUBICIN IN HUMAN BREAST-CANCER CELLS

被引:10
作者
BONTENBAL, M [1 ]
SIEUWERTS, AM [1 ]
PETERS, HA [1 ]
SONNEVELD, P [1 ]
FOEKENS, JA [1 ]
KLIJN, JGM [1 ]
机构
[1] ERASMUS UNIV,HOSP DIJKZIGT,DEPT HEMATOL,3015 GD ROTTERDAM,NETHERLANDS
关键词
D O I
10.1016/0960-0760(90)90472-W
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In vitro exposure of estrogen receptor-negative (ER-) EVSA-T human breast cancer cells to insulin and/or estradiol had no effect on cell cycle distribution, in contrast to a 3-5-fold increase in the percentages of cells in the S-phase of the cell cycle in the ER+ MCF-7 cell line. Estrogen pretreatment of MCF-7 cells followed by incubation with doxorubicin resulted in an augmented inhibition of cell growth compared to unstimulated controls. This delay in growth was accompanied by a decrease in the percentages of cells actively synthesizing DNA, and by an augmented percentage of cells exhibiting a G2M-amount of DNA at the end of a 6-9 day period of culture in complete growth medium.
引用
收藏
页码:1097 / 1101
页数:5
相关论文
共 17 条
[1]  
ALLEGRA JC, 1983, SEMIN ONCOL, V10, P23
[2]   EFFECT OF HORMONAL MANIPULATION AND DOXORUBICIN ADMINISTRATION ON CELL-CYCLE KINETICS OF HUMAN-BREAST CANCER-CELLS [J].
BONTENBAL, M ;
SIEUWERTS, AM ;
KLIJN, JGM ;
PETERS, HA ;
KRIJNEN, HLJM ;
SONNEVELD, P ;
FOEKENS, JA .
BRITISH JOURNAL OF CANCER, 1989, 60 (05) :688-692
[3]   ESTRADIOL ENHANCES DOXORUBICIN UPTAKE AND CYTO-TOXICITY IN HUMAN-BREAST CANCER-CELLS (MCF-7) [J].
BONTENBAL, M ;
SONNEVELD, P ;
FOEKENS, JA ;
KLIJN, JGM .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (09) :1409-1414
[4]   ESTROGEN-RECEPTOR STATUS AND THE RESPONSE OF HUMAN-BREAST CANCER CELL-LINES TO A COMBINATION OF METHOTREXATE AND 17-BETA ESTRADIOL [J].
CLARKE, R ;
VANDENBERG, HW ;
KENNEDY, DG ;
MURPHY, RF .
BRITISH JOURNAL OF CANCER, 1985, 51 (03) :365-369
[5]   CONVENTIONAL VERSUS CYTOKINETIC POLYCHEMOTHERAPY WITH ESTROGENIC RECRUITMENT IN METASTATIC BREAST-CANCER - RESULTS OF A RANDOMIZED COOPERATIVE TRIAL [J].
CONTE, PF ;
PRONZATO, P ;
RUBAGOTTI, A ;
ALAMA, A ;
AMADORI, D ;
DEMICHELI, R ;
GARDIN, G ;
GENTILINI, P ;
JACOMUZZI, A ;
LIONETTO, R ;
MONZEGLIO, C ;
NICOLIN, A ;
ROSSO, R ;
SISMONDI, P ;
SUSSIO, M ;
SANTI, L .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (03) :339-347
[6]   ESTROGEN POTENTIATES TOPOISOMERASE-II-MEDIATED CYTO-TOXICITY IN AN ACTIVATED SUBPOPULATION OF HUMAN-BREAST CANCER-CELLS - IMPLICATIONS FOR CYTO-TOXIC DRUG-RESISTANCE IN SOLID TUMORS [J].
EPSTEIN, RJ ;
SMITH, PJ ;
WATSON, JV ;
WATERS, C ;
BLEEHEN, NM .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (03) :501-505
[7]   CHARACTERIZATION OF VP-16-INDUCED DNA CLEAVAGE IN ESTROGEN-STIMULATED HUMAN-BREAST CANCER-CELLS [J].
EPSTEIN, RJ ;
SMITH, PJ ;
WATSON, JV ;
BLEEHEN, NM .
BRITISH JOURNAL OF CANCER, 1988, 57 (05) :445-450
[8]  
EPSTEIN RJ, 1988, CANCER RES, V48, P297
[9]   ADJUVANT CHEMOTHERAPY WITH AND WITHOUT TAMOXIFEN IN THE TREATMENT OF PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT TRIAL [J].
FISHER, B ;
REDMOND, C ;
BROWN, A ;
FISHER, ER ;
WOLMARK, N ;
BOWMAN, D ;
PLOTKIN, D ;
WOLTER, J ;
BORNSTEIN, R ;
LEGAULTPOISSON, S ;
SAFFER, EA .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) :459-471
[10]  
HUG V, 1986, CANCER RES, V46, P147